JAMES A. JOHNSON - 29 Mar 2023 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
/s/ Glenna Mileson, attorney-in-fact on behalf of James A. Johnson
Issuer symbol
ATHA
Transactions as of
29 Mar 2023
Net transactions value
+$12,000
Form type
4
Filing time
30 Mar 2023, 18:59:29 UTC
Previous filing
27 May 2022
Next filing
22 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Purchase $12,000 +5,000 $2.40 5,000 29 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.